Disclosure 0001837798-26-000013-1

SEC FORM 4

$355,945.75

Aurinia Pharmaceuticals Inc. (AUPH)

Sale of 20,975 shares at $16.97 per share.

Reporting Person Robertson Stephen P. · Officer Title Chief Legal Officer · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001837798-26-000013 · filed 2026-08-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Aurinia Pharmaceuticals Inc. (AUPH)." Disclosed 2026-08-25. https://desqlong.com/cards/0001837798-26-000013-1 (retrieved 2026-09-26).